http://mdbooksfree.blogspot.com/2012/03/drug-formulation-free.html
http://www.patentdocs.org/2010/02/reverse-payments-in-generic-drug-settlements-part-ii.html
https://www.govtrack.us/congress/bills/108/hr1
http://globenewswire.com/news-release/2013/02/28/527367/0/en/FDA-approves-once-monthly-Abilify-Maintena-aripiprazole-for-extended-release-injectable-suspension-for-the-treatment-of-schizophrenia.html
http://www.cga.ct.gov/lrc/drugpolicy/DrugPolicyRpt2.htm
http://mdbooksfree.blogspot.com/2012/03/managing-suicidal-risk-free.html
http://www.patentdocs.org/2014/11/judge-sheridan-dismisses-more-plaintiffs-in-lipitor-antitrust-case.html
http://finance.yahoo.com/news/fda-accepts-review-otsuka-pharmaceutical-130000091.html
http://www.gpo.gov/fdsys/pkg/CFR-2000-title45-vol4/xml/CFR-2000-title45-vol4.xml
http://codes.ohio.gov/orc/2307
http://www.zurinstitute.com/riskmanagement.html
http://www.policymed.com/
http://www.hivguidelines.org/clinical-guidelines/adults/hiv-drug-drug-interactions/
http://www.guideline.gov/content.aspx?id=9317
http://en.wikipedia.org/wiki/Credit_risk
http://www.jhsph.edu/research/centers-and-institutes/center-for-drug-safety-and-effectiveness/academic-training/Course_Work/Course%20Work
http://cclawyer.cccba.org/2011/06/substantiating-the-tax-treatment-of-settlement-payments/
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5019a1.htm
http://www.pharmaceuticalonline.com/doc/pfizer-off-label-liability-expanded-0001
http://www.traydunaway.com/risk.html
http://www.academia.edu/2603351/Patterns_of_prescription_drug_use_and_incidence_of_drug_drug_interactions_in_patients_reporting_to_medical_emergency
http://www.heritage.org/research/reports/2004/05/compromising-quality-the-high-cost-of-government-drug-purchasing
http://www.cardiosource.org/News-Media/Media-Center/News-Releases/2013/11/ACC-AHA-Cholesterol-Guidelines-Statement.aspx
http://www.mondaq.com/unitedstates/x/37270/Healthcare/CMS+Issues+Final+Rule+on+Competitive+Acquisition+of+Medicare+Part+B+Drugs+and+Biologicals
http://agreements.realdealdocs.com/Manufacturing-Agreement/PRODUCT-DEVELOPMENT-CONTRACT-MANUFACTURI-2857224/
http://www.researchgate.net/journal/1099-1557_Pharmacoepidemiology_and_Drug_Safety
http://investor.ligand.com/Investors/News-and-Events/Press-Releases/Press-Release-Details/2013/Ligand-Partner-Rib-X-Initiates-Phase-3-Trial-of-Captisol-enabled-Delafloxacin-IV/default.aspx
http://healthaffairs.org/blog/2013/06/21/ftc-v-actavis-the-supreme-court-issues-a-reversal-on-reverse-payments/
http://www.janssencns.com/
http://www.pharmtech.com/pharmtech/Regulatory+Corner/Regulatory-Roundup/ArticleStandard/Article/detail/813487
http://www.hhs.gov/ohrp/archive/irb/irb_chapter3.htm
http://www.policymed.com/clinical-research/
http://www.fda.gov/ohrms/dockets/ac/03/transcripts/3980T1.htm
http://www.hiv.va.gov/provider/manual-primary-care/substance-use.asp
http://www.iowamedicalmarijuana.org/documents/nc1ch5.aspx
http://health.gov.ie/blog/press-release/publication-of-the-report-of-the-expert-group-on-the-judgment-in-a-b-and-c-v-ireland/
http://www.pharmtech.com/pharmtech/News/JampJ-Fined-22-Billion-for-Off-label-Marketing-and/ArticleStandard/Article/detail/827524
http://quizlet.com/5862328/risk-management-and-governance-flash-cards/
http://www.ukessays.com/essays/engineering/quality-management-system-and-pharmaceuticals.php
http://www.horizon-bcbsnj.com/pdf/tazorac.pdf
http://www.naturalproductsinsider.com/sitecore/content/repository/nutrition/articles/2006/05/risk-and-litigation-avoidance-in-addition-to-liabi.aspx
http://www.horizon-bcbsnj.com/pdf/Actimmune.pdf
http://www.fool.com/investing/businesswire/2013/05/14/ligand-partner-rib-x-initiates-phase-3-trial-of-ca.aspx
http://www.nas.edu/21st/health/health.html
http://www.econlib.org/library/Knight/knRUP9.html
